Filing Details

Accession Number:
0001535264-25-000002
Form Type:
13G Filing
Publication Date:
2025-01-12 19:00:00
Filed By:
AWM Investment Company, Inc.
Company:
Cervomed Inc. (NASDAQ:CRVO)
Filing Date:
2025-01-13
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
AWM Investment Company, Inc. 0 405,165 4.7%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  **AWM Investment Company, Inc., a Delaware Corporation (AWM), is the investment adviser to Special Situations Cayman Fund, L.P. (CAYMAN), Special Situations Fund III QP, L.P. (SSFQP) and Special Situations Life Sciences Fund, L.P. (SSLS). (CAYMAN, SSFQP, and SSLS will hereafter be referred to as the Funds). As the investment adviser to the Funds, AWM holds sole voting and investment power over 0 shares of Common Stock of the Issuer (the Shares) and 235,126 Warrants*** to purchase Shares of Common Stock held by SSFQP, 0 shares of Common Stock and 68,748 Warrants*** to purchase Shares of Common Stock held by CAYMAN and 0 shares of Common Stock and 101,291 Warrants*** to purchase Shares of Common Stock held by SSLS. The Warrants described herein may only be exercised to the extent that the total number of Common Shares then beneficially owned does not exceed 4.99% of the outstanding shares


SCHEDULE 13G


 
AWM Investment Company, Inc.
 
Signature:Adam Stettner
Name/Title:Executive Vice President
Date:01/08/2025